Rothschild & Co Asset Management US’s AMAG Pharmaceuticals, Inc. AMAG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2017
Q3
Sell
-40,132
Closed -$738K 568
2017
Q2
$738K Sell
40,132
-1,812
-4% -$33.3K 0.01% 400
2017
Q1
$946K Sell
41,944
-3,102
-7% -$70K 0.01% 373
2016
Q4
$1.57M Buy
45,046
+35,360
+365% +$1.23M 0.02% 354
2016
Q3
$237K Buy
9,686
+244
+3% +$5.97K ﹤0.01% 523
2016
Q2
$226K Sell
9,442
-299,723
-97% -$7.17M ﹤0.01% 551
2016
Q1
$7.23M Buy
309,165
+5,073
+2% +$119K 0.14% 222
2015
Q4
$9.18M Buy
304,092
+15,539
+5% +$469K 0.17% 196
2015
Q3
$11.5M Buy
288,553
+162,668
+129% +$6.46M 0.22% 156
2015
Q2
$8.69M Buy
125,885
+1,240
+1% +$85.6K 0.16% 211
2015
Q1
$6.81M Buy
124,645
+31,657
+34% +$1.73M 0.13% 235
2014
Q4
$3.96M Buy
92,988
+173
+0.2% +$7.37K 0.08% 276
2014
Q3
$2.96M Sell
92,815
-3,680
-4% -$117K 0.06% 300
2014
Q2
$2M Hold
96,495
0.04% 326
2014
Q1
$1.87M Sell
96,495
-44,812
-32% -$867K 0.04% 337
2013
Q4
$3.43M Buy
141,307
+27,258
+24% +$662K 0.08% 310
2013
Q3
$2.45M Sell
114,049
-20,006
-15% -$430K 0.05% 323
2013
Q2
$2.98M Buy
+134,055
New +$2.98M 0.07% 315